Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-I

Status: Completed
Location: See all (2) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study study is a prospective, single-arm, multicenter study to evaluate the safety and effectiveness of the Vertex Pulmonary Embolectomy System in participants presenting with clinical signs and symptoms of pulmonary embolism.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 79
Healthy Volunteers: f
View:

• Age ≥ 18 years \< 80 years

• Acute onset of symptoms ≤ 14 days consistent with the presence of pulmonary embolism.

• CTA evidence (site determined) of proximal PE (filling defect in at least one main or interlobar pulmonary artery)

• RV/LV ratio of \> 0.9 on CTA as assessed by investigator (site determined).

• Systolic blood pressure ≥ 90 mmHg (initial SBP may be ≥ 80 mmHg if the pressure recovers to ≥ 90 mmHg with fluids)

• Subject is willing and able to provide written informed consent prior to receiving any non-standard of care clinical investigation plan specific procedures

• Subject is willing and able to comply with all clinical investigation plan required follow-up visits

Locations
Other Locations
Austria
AKH Vienna - Medical university of Vienna
Vienna
Poland
Jagiellonian University
Krakow
Time Frame
Start Date: 2024-09-10
Completion Date: 2025-05-21
Participants
Target number of participants: 10
Treatments
Experimental: Vertex Pulmonary Embolectomy System
Patients presenting with clinical signs and symptoms of acute pulmonary embolism and who meet the study criteria will be treated with the Vertex Pulmonary Embolectomy System
Related Therapeutic Areas
Sponsors
Leads: Neptune Medical

This content was sourced from clinicaltrials.gov